This Product Review focusses on dexamethasone intravitreal implant in the treatment of diabetic macular oedema.
Guiding commentary has been supplied by Professor Mark Gillies, a clinician scientist who is Director of Research, Save Sight Institute, and of the Macula Research Group of the University of Sydney.
Please login below to download this issue (PDF)